Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms in Patients Infected With the SARS-CoV-2 Virus

NCT04854759 is registered in ClinicalTrials.gov with Independent Public Clinical Hospital No. 4 in Lublin as lead sponsor.

NCT NCT04854759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04854759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms in Patients Infected With the SARS-CoV-2 Virus
Lead sponsor
Independent Public Clinical Hospital No. 4 in Lublin
Phase
Phase 3
Overall status
Unknown status
Start date
March 15, 2021
Completion date
May 31, 2022
Enrollment
200 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2